REFERENCES
- Aso Y, Boccon-Gibod L, Calais Da Silva F, et al. Subjective response, objective response, impact on quality of life. In Cockett ATK, Aso Y, Chatelain C et al. eds. The international consultation on benign prostatic hyperplasia (BPH). Ivry, Seine: Digital Print, 1991: 87–90.
- Bardsley MJ, Venning PM, Cham CW, Hasan T, Neal DE. A self administered patient questionnaire in the evaluation of symptoms before and after prostatectomy. Br J Urol 1992; 69: 375–380.
- Boyarsky S, Jones G, Paulson DF and Prout GRJr. A new look at bladder neck obstruction by Food and Drug Administration regulators: guidelines for the investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg 1977; 68: 29–32.
- Epstein RS, Deverka PA, Chute CG, et al. Urinary symptom and quality of life questions indicative for benign prostatic hyperplasia: Results of a pilot study. Urology 1991 Suppl; 38: 20–26.
- Fowler FJ, Wenneberg JE, Timothy RP, et al. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018–3022.
- Hald T, Nordling J, Andersen JT, Bilde T, Mey-hoff HH and Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 1991 Suppl; 138: 59–62.
- Madsen PO and Iversen P. A point system for selecting operative candidates. In Hinman FJr ed. Benign prostatic hypertropy. New York, Heidelberg, Berlin: Springer Verlag 1983: 763–765.
- Mebust W, Roizo R, Schroeder F and Villers A. Correlation between pathology, clinical symptoms and the course of the disease. In Cockett ATK, Aso Y, Chatelain C et al. eds. The international consultation on benign prostatic hyperplasia (BPH). Ivry, Seine: Digital Print, 1991: 53–62.